Cite
MLA Citation
Paolo A Ascierto et al.. “Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial.” Lancet oncology, vol. 18, no. 5, n.d., pp. 611–622. http://access.bl.uk/ark:/81055/vdc_100045920700.0x00005c